Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2002;39:161-167
doi: 10.1161/hy1201.097201
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hofbauer, K.-H.
Right arrow Articles by Sandner, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hofbauer, K.-H.
Right arrow Articles by Sandner, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology
Right arrow Gene expression
Right arrow Gene regulation
Right arrow Physiological and pathological control of gene expression

(Hypertension. 2002;39:161.)
© 2002 American Heart Association, Inc.


Scientific Contributions

Inflammatory Cytokines Stimulate Adrenomedullin Expression Through Nitric Oxide–Dependent and –Independent Pathways

Karl-Heinz Hofbauer; Ellen Schoof; Armin Kurtz; Peter Sandner

From the Institut für Physiologie der Universität Regensburg (K.-H.H., A.K., P.S.), Regensburg, Germany; and Klinik für Kinder und Jugendliche (E.S.), Erlangen, Germany.

Correspondence to Armin Kurtz, MD, Institut für Physiologie I, Universität Regensburg, D-93040 Regensburg, Germany. E-mail armin.kurtz{at}vkl.uni-regensburg.de

A body of evidence indicates that the production of adrenomedullin (ADM) in vivo is activated in states of inflammation. Our aim was to characterize the intracellular signaling pathways along which inflammation leads to a stimulation of ADM expression. For this purpose, we characterized the effects of inflammatory cytokines, tumor necrosis factor-{alpha} (100 µg/L), interleukin-1ß (20 µg/L), and interferon-{gamma} (0.5 U/L) on ADM gene expression in rat aortic vascular smooth muscle cells (AVSMCs). We found that inflammatory cytokines induced a time-dependent 12-fold upregulation of ADM mRNA in AVSMCs that was paralleled by a substantial increase in inducible NO synthase mRNA expression. The stimulatory effect of cytokines on ADM gene expression was attenuated by NO deprivation induced by N{omega}-nitro-L-arginine methyl ester (1 mmol/L) and was in part mimicked by the NO donor S-nitroso-N-acetylpenicillamine (100 µmol/L). The cGMP analog 8-bromo-cGMP (100 µmol/L) had no effect on ADM gene expression, and inhibition of cGMP production by 1H-oxodiazolo-quinoxalin-1 (ODQ, 200 µmol/L) was not able to abrogate the increase of ADM mRNA induced by NO donation using S-nitroso-N-acetylpenicillamine (100 µmol/L). The significant induction of ADM gene expression by inflammatory cytokines and NO donation was also observed in mesangial cells, endothelial cells, and hepatocytes. These findings suggest that NO is a direct activator of ADM gene expression in a variety of cell types and that inflammatory cytokines stimulate ADM expression via both NO-dependent and -independent mechanisms. The stimulatory effect of NO appears to not be related to the classic guanylate cyclase–cGMP pathway.


Key Words: nitric oxide • adrenomedullin • cytokines • muscle, smooth, vascular




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
S. Oba, M. Hino, and T. Fujita
Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant
Nephrol. Dial. Transplant., February 1, 2008; 23(2): 510 - 517.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
I. S. S. Hwang, M. L. Fung, E. C. Liong, G. L. Tipoe, and F. Tang
Age-Related Changes in Adrenomedullin Expression and Hypoxia-Inducible Factor-1 Activity in the Rat Lung and Their Responses to Hypoxia
J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 41 - 49.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
A. Al-Ghafra, N.M. Gude, S.P. Brennecke, and R.G. King
Increased adrenomedullin protein content and mRNA expression in human fetal membranes but not placental tissue in pre-eclampsia
Mol. Hum. Reprod., March 1, 2006; 12(3): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Frede, P. Freitag, T. Otto, C. Heilmaier, and J. Fandrey
The Proinflammatory Cytokine Interleukin 1{beta} and Hypoxia Cooperatively Induce the Expression of Adrenomedullin in Ovarian Carcinoma Cells through Hypoxia Inducible Factor 1 Activation
Cancer Res., June 1, 2005; 65(11): 4690 - 4697.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. Agorreta, J. J. Zulueta, L. M. Montuenga, and M. Garayoa
Adrenomedullin expression in a rat model of acute lung injury induced by hypoxia and LPS
Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L536 - L545.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. S. Chung, M. Packer, K. H. Lo, A. A. Fasanmade, and J. T. Willerson
Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-{alpha}, in Patients With Moderate-to-Severe Heart Failure: Results of the Anti-TNF Therapy Against Congestive Heart failure (ATTACH) Trial
Circulation, July 1, 2003; 107(25): 3133 - 3140.
[Abstract] [Full Text] [PDF]